News Daily

The Times

News from Asia

  • Written by Media Outreach
SINGAPORE - Media OutReach Newswire - 19 July 2024 - Zuellig Pharma, a leading healthcare solutions company in Asia, today announced that it has signed a 10-year commercialisation partnership with Austria-based Institut AllergoSan, a research and development company that specialises in products made from natural substances such as probiotic bacteria, plant extracts and minerals.

Anita Frauwallner, founder and CEO of Institut AllergoSan (left) and John Graham, Group CEO, Zuellig Pharma (right) at the partnership signing ceremony to bring OMNi-BiOTiC® to key markets in Asia.

Under this partnership, Zuellig Pharma will provide a wide spectrum of commercialisation support, including product registration, sales and marketing, and warehousing and distribution services to bring OMNi-BiOTiC®, one of Institut AllergoSan's leading probiotic brands, to key markets in Asia.

"Our consumer healthcare segment will be one of the key growth drivers in our business over the coming years and this partnership represents a significant step forward in our commitment to delivering innovative and accessible healthcare solutions to patients in Asia. With a fast-growing probiotics market in Asia, the comprehensive and tailored solutions offered through our commercialisation division, ZP Therapeutics, will help our partners expand their footprint to meet greater consumer demand for gut health products in this region. Together with Institut AllergoSan, we will leverage our combined expertise to enhance the well-being of consumers and drive forward our mission of making healthcare more accessible," said John Graham, Group CEO, Zuellig Pharma.

"We are dedicated to supporting consumers' pursuit of a healthier, more vital self and offer medically relevant probiotic supplements that target specific health needs and deliver clinically backed results. OMNi-BiOTiC® is the top selling probiotic brand in all German-speaking markets in Europe such as Austria, Germany and Switzerland[1] and we look forward to working closely with Zuellig Pharma to bring these innovative products to everybody in Asia who wants to promote an active, healthy life," adds Anita Frauwallner, founder and CEO of Institut AllergoSan.

Zuellig Pharma plans to launch OMNi-BiOTiC® in Indonesia, the Philippines and Taiwan in 2025, followed by other key markets thereafter.

[1] IQVIA OTC Global Insights 2023, 03F1/A7F, IQVIA OTC Audits / Public Price in EUR.

Hashtag: #ZuelligPharma #InstitutAllergoSan #Healthcare #Probiotics #ConsumerHealthcare #GutHealth #Commercialisation

The issuer is solely responsible for the content of this announcement.

Read more

Why Compact Designs of Caravan Travel Transform Short Getaways

A caravan makes exploring Australia more flexible. For many Australians, a compact and practical setup makes short breaks easier, more comfortable and far more spontaneous. The layout inside significantly impacts how comfortable, organised and enjoyable your travels become.  Travellers often compare... Read more

7 Situations Where GPR Scanning Can Prevent Costly Construction Mistakes

Construction projects often rely on accurate information before excavation, drilling, coring or demolition begins. While plans, utility records and visual inspections provide valuable guidance, they don't always reveal what's hidden beneath the surface. Unknown utilities, reinforcement, voids or buried structures... Read more

Key Terms to Review Before Signing a Business Lease

A business lease can be a large financial commitment, and the terms buried in the fine print can affect your operation for years. It can be tempting to skim past the legal detail once you’ve found premises you like, but... Read more

When Should You Speak to Bankruptcy Lawyers About Debt Problems?

Debt problems rarely appear without warning, yet many people wait far longer than they should before seeking legal advice about their situation. By the time the decision is made to consult with bankruptcy lawyers, the available options are often more... Read more

Top Electrical Safety Tips from Inner West Sydney Electricians

While it may not be the most exciting subject to discuss, having an electrically safe home is definitely one of the most critical. Knowing the basics could help you avoid accidents and ensure your home remains in good condition, whether... Read more

When to Escalate a Debt Recovery Matter to Legal Action

Knowing when to transition from informal debt collection efforts to formal legal proceedings is a decision that many creditors find difficult to navigate. Acting too early can damage commercial relationships, while waiting too long can reduce the likelihood of recovery... Read more